×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RLYB – rallybio corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RLYB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/22
08:12 am
rlyb
Rallybio Co. (NASDAQ: RLYB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Medium
Report
Rallybio Co. (NASDAQ: RLYB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
11/22
07:38 am
rlyb
Rallybio commences Phase II trial of RLYB212 for FNAIT in pregnant women [Yahoo! Finance]
Medium
Report
Rallybio commences Phase II trial of RLYB212 for FNAIT in pregnant women [Yahoo! Finance]
11/21
08:27 am
rlyb
Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212 [Yahoo! Finance]
Low
Report
Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212 [Yahoo! Finance]
11/21
08:00 am
rlyb
Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212
Low
Report
Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212
11/8
02:32 pm
rlyb
Rallybio Co. (NASDAQ: RLYB) had its price target lowered by analysts at HC Wainwright from $6.00 to $5.00. They now have a "buy" rating on the stock.
Low
Report
Rallybio Co. (NASDAQ: RLYB) had its price target lowered by analysts at HC Wainwright from $6.00 to $5.00. They now have a "buy" rating on the stock.
11/7
08:00 am
rlyb
Rallybio Reports Third Quarter 2024 Financial Results and Provides Business Updates
Low
Report
Rallybio Reports Third Quarter 2024 Financial Results and Provides Business Updates
10/30
09:25 am
rlyb
Rallybio Co. (NASDAQ: RLYB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Rallybio Co. (NASDAQ: RLYB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
10/29
08:00 am
rlyb
Rallybio Announces Approval of Clinical Trial Applications for Phase 2 Trial of RLYB212 in Pregnant Women at Higher Risk of Alloimmunization and FNAIT
Medium
Report
Rallybio Announces Approval of Clinical Trial Applications for Phase 2 Trial of RLYB212 in Pregnant Women at Higher Risk of Alloimmunization and FNAIT
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
10:34 am
rlyb
Form SC 13G/A Rallybio Corp Filed by: FMR LLC
Medium
Report
Form SC 13G/A Rallybio Corp Filed by: FMR LLC
11/7
04:11 pm
rlyb
Form 10-Q Rallybio Corp For: Sep 30
Low
Report
Form 10-Q Rallybio Corp For: Sep 30
11/7
08:12 am
rlyb
Form 8-K Rallybio Corp For: Nov 07
Low
Report
Form 8-K Rallybio Corp For: Nov 07
9/17
08:27 am
rlyb
Form 8-K Rallybio Corp For: Sep 16
Neutral
Report
Form 8-K Rallybio Corp For: Sep 16
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: